Molecular mechanisms researches demonstrated that overexpression of protein-coupled receptor GPR87 enhanced pancreatic cancer aggressiveness by activating NF-κB signaling pathway [7]. The gene discussed is NFKB1; the disease is familial pancreatic carcinoma.